Cover Image
市場調查報告書

歐洲的醫藥品、醫療產業 (季度更新報告)

Europe Pharmaceuticals & Healthcare Report Q4 2017

出版商 BMI Research 商品編碼 363589
出版日期 內容資訊 英文 48 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的醫藥品、醫療產業 (季度更新報告) Europe Pharmaceuticals & Healthcare Report Q4 2017
出版日期: 2017年10月24日 內容資訊: 英文 48 Pages
簡介

本報告提供歐洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區的詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 歐洲市場最新形勢

SWOT分析

  • 歐洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 歐洲:風險/利潤指標

市場概況

  • 歐洲市場最新形勢

產業的趨勢與發展

  • 歐洲市場最新形勢

域內市場概況

  • 歐洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SSOE03_20171001

BMI View: Opportunities for multinational pharmaceutical firms differ between the developed Western and the emerging European markets. While innovative drugmakers will continue to favour the developed markets, they will face headwinds in the form of increasing cost-containment in the face of rising demand for chronic disease treatments. Emerging European markets will continue to represent high-growth opportunities due to expansion of healthcare access, although these markets will be favoured primarily by generic drug manufacturers.

Table of Contents

BMI Industry View

  • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2015-2021)

SWOT

  • Industry Forecast
  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts, Europe (2013-2021)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts, Europe (2013-2021)

Industry Risk Reward Index

  • Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
  • Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities

Market Overview

Industry Trend Analysis

  • Regional Themes - Europe

Industry Trends & Developments

  • Industry Trends And Developments
    • Table: Europe Pharmaceutical Market (USDbn)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top